Healthcare -
Biotechnology - NASDAQ - US
$ 39.47
0.895 %
$ 2.35 B
Market Cap
14.41
P/E
PTGX - GROSS PROFIT
Gross Profit PTGX - Protagonist Therapeutics, Inc.
60 M
LAST VALUE
56.23%
2 YEAR CAGR
14.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR